$0.40
8.13% yesterday
Nasdaq, Apr 03, 10:00 pm CET
ISIN
US37148K1007
Symbol
GBIO
Sector
Industry

Generation Bio Co Target price 2025 - Analyst rating & recommendation

Generation Bio Co Classifications & Recommendation:

Buy
67%
Hold
33%

Generation Bio Co Price Target

Target Price $6.75
Price $0.40
Potential
Number of Estimates 4
4 Analysts have issued a price target Generation Bio Co 2026 . The average Generation Bio Co target price is $6.75. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 4 Analysts recommend Generation Bio Co to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Generation Bio Co stock has an average upside potential 2026 of . Most analysts recommend the Generation Bio Co stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 19.89 5.62
237.12% 71.77%
Net Margin -666.67% -1,180.77%
70.03% 77.11%

6 Analysts have issued a sales forecast Generation Bio Co 2025 . The average Generation Bio Co sales estimate is

$5.6m
Unlock
. This is
71.77% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$16.2m 18.55%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $19.9m 237.12%
2025
$5.6m 71.77%
Unlock
2026
$6.0m 6.46%
Unlock
2027
$10.3m 72.66%
Unlock
2028
$8.1m 21.52%
Unlock
2029
$83.5m 930.86%
Unlock

1 Analyst has issued a net profit forecast Generation Bio Co 2025 . The average Generation Bio Co net profit estimate is

$-66.3m
Unlock
. This is
50.00% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-66.3m 50.00%
Unlock
, the lowest is
$-66.3m 50.00%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-133m 1.02%
2025
$-66.3m 50.00%
Unlock
2026
$-48.2m 27.27%
Unlock
2027
$-42.9m 11.12%
Unlock
2028
$-44.2m 3.13%
Unlock

Net Margin

2024 -666.67% 70.03%
2025
-1,180.77% 77.11%
Unlock
2026
-806.60% 31.69%
Unlock
2027
-415.25% 48.52%
Unlock
2028
-545.68% 31.41%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.98 -0.99
1.02% 50.00%
P/E negative
EV/Sales negative

1 Analysts have issued a Generation Bio Co forecast for earnings per share. The average Generation Bio Co EPS is

$-0.99
Unlock
. This is
50.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.99 50.00%
Unlock
, the lowest is
$-0.99 50.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.98 1.02%
2025
$-0.99 50.00%
Unlock
2026
$-0.72 27.27%
Unlock
2027
$-0.64 11.11%
Unlock
2028
$-0.66 3.13%
Unlock

P/E ratio

Current -0.20 90.34%
2025
-0.40 100.00%
Unlock
2026
-0.55 37.50%
Unlock
2027
-0.62 12.73%
Unlock
2028
-0.60 3.23%
Unlock

Based on analysts' sales estimates for 2025, the Generation Bio Co stock is valued at an EV/Sales of

-11.58
Unlock
and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -3.27 118.54%
2025
-11.58 254.12%
Unlock
2026
-10.88 6.07%
Unlock
2027
-6.30 42.08%
Unlock
2028
-8.03 27.43%
Unlock
2029
-0.78 90.30%
Unlock

P/S ratio

Current 1.34 97.08%
2025
4.74 254.22%
Unlock
2026
4.46 6.07%
Unlock
2027
2.58 42.08%
Unlock
2028
3.29 27.43%
Unlock
2029
0.32 90.30%
Unlock

Current Generation Bio Co Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked Mar 17 2025
Citizens Capital Markets
Locked
Locked
Locked Mar 14 2025
Needham
Locked
Locked
Locked Mar 14 2025
Needham
Locked
Locked
Locked Jan 08 2025
Needham
Locked
Locked
Locked Oct 23 2024
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
Mar 17 2025
Locked
Citizens Capital Markets:
Locked
Locked
Mar 14 2025
Locked
Needham:
Locked
Locked
Mar 14 2025
Locked
Needham:
Locked
Locked
Jan 08 2025
Locked
Needham:
Locked
Locked
Oct 23 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today